Article Details
Retrieved on: 2025-05-29 10:53:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
South Korea's Samsung Biologics is expanding its manufacturing capabilities, focusing on monoclonal antibodies and antibody-drug conjugates. The ...
Article found on: www.openpr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here